Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
April 30, 2019 Off

Xencor Announces Partial Clinical Hold Lifted on Phase 1 Study of XmAb®14045

By BusinessWire

MONROVIA, Calif.–(BUSINESS WIRE)–Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of cancer, autoimmune diseases,…

April 30, 2019 Off

Inscripta Appoints Ron McGrath as Chief Financial Officer

By BusinessWire

BOULDER, Colo.–(BUSINESS WIRE)–Inscripta, developer of the first scalable platform for benchtop Digital Genome Engineering, today announced the appointment of Ron…

April 30, 2019 Off

Grand River Aseptic Manufacturing, Inc. Implements Fully-Automated Serialization and Aggregation Solutions Ahead of 2023 DSCSA Deadline

By BusinessWire

GRAND RAPIDS, Mich.–(BUSINESS WIRE)–Grand River Aseptic Manufacturing, Inc. (GRAM), a leading parenteral contract development and manufacturing organization, has implemented its…

April 30, 2019 Off

Agilent and SomaLogic Sign Agreement for Supply of Custom Microarrays

By BusinessWire

Use of Agilent’s custom microarrays in the SOMAscan® assay will help drive biomarker discovery efforts as well as novel diagnostics…

April 30, 2019 Off

Global Market for Cell Therapy & Tissue Engineering – Market Size, Forecasts, Technologies & Trends, 2019 – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Market for Cell Therapy and Tissue Engineering – Market Size, Forecasts, Technologies & Trends” report has been added…

April 30, 2019 Off

KalVista Pharmaceuticals Presents Data at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting 2019

By BusinessWire

– Novel Oral Plasma Kallikrein Inhibitors KV998052 and KV998054 Prevent and Reverse VEGF-Induced Retinal Edema in Mice – CAMBRIDGE, Mass.…

Aerie Pharmaceuticals to Announce First Quarter 2019 Financial Results and Host Conference Call on Tuesday, May 7, 2019
April 30, 2019 Off

Aerie Pharmaceuticals to Announce First Quarter 2019 Financial Results and Host Conference Call on Tuesday, May 7, 2019

By BusinessWire

DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies…

April 30, 2019 Off

Novocure: Higher doses of tumor treating fields improved survival of newly diagnosed glioblastoma patients

By BusinessWire

The study provides a definition for Tumor Treating Fields dose and sets a framework for future work on Tumor Treating…

April 30, 2019 Off

Global Stem Cell Assay Market (2020-2025 Outlook): High Tech & Emerging Markets Report, 2019 – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “2019 Global Forecast for Stem Cell Assay (2020-2025 Outlook) – High Tech & Emerging Markets Report” report has…

April 30, 2019 Off

Incyte Reports 2019 First Quarter Financial Results and Provides Updates on Key Clinical Programs

By BusinessWire

Total revenues of $498 million (+30% vs Q1 2018) and total product-related revenues of $458 million (+20% vs Q1 2018) for the…

Posts pagination

Previous 1 … 3,242 3,243 3,244 … 3,606 Next

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine